Pharmabiz58m
Merck’s STRIDE-8 phase 3 trial of Capvaxive demonstrates positive immune responses in adults with increased risk for pneumococcal disease
Merck’s STRIDE-8 phase 3 trial of Capvaxive demonstrates positive immune responses in adults with increased risk for pneumococcal disease: Rahway, New Jersey Thursday, October 1 ...
Pharmabiz1h
US FDA accepts for priority review GSK’s NDA for gepotidacin to treat uncomplicated urinary tract infections in female adults and adolescents
US FDA accepts for priority review GSK’s NDA for gepotidacin to treat uncomplicated urinary tract infections in female adults and adolescents: London, UK Thursday, October 17, 2 ...
Pharmabiz2h
NABH introduces first-ever Care Home Accreditation Standards to improve quality & safety in home care
NABH introduces first-ever Care Home Accreditation Standards to improve quality & safety in home care: Shardul Nautiyal, Mumbai Thursday, October 17, 2024, 08:00 Hrs [IST] In a la ...
Pharmabiz2h
Indian pharma & nutra sectors opt for LipoDuo technology to enhance stability & bioavailability factors
Indian pharma & nutra sectors opt for LipoDuo technology to enhance stability & bioavailability factors: Nandita Vijayasimha, Bengaluru Thursday, October 17, 2024, 08:00 Hrs [IST] ...
Pharmabiz2h
NABH announces certification programme for HIS/EMR Systems
The National Accreditation Board for Hospitals and Healthcare Providers (NABH) has introduced a new certification programme for Hospital Information Systems (HIS) and Electronic Medical Records (EMR) ...
Pharmabiz2h
DoP directs NPPA to recalculate ceiling prices of three antibiotics based on Cipla's applications
DoP directs NPPA to recalculate ceiling prices of three antibiotics based on Cipla's applications: Gireesh Babu, New Delhi Thursday, October 17, 2024, 08:00 Hrs [IST] The Departme ...
Pharmabiz11h
MaaT Pharma completes recruitment in ARES phase 3 trial for MaaT013 to treat acute graft-versus-host disease
MaaT Pharma, a clinical-stage biotechnology company, announced full recruitment of its phase 3 clinical trial designed to evaluate efficacy and safety of its lead asset MaaT013 in the treatment of ...
Pharmabiz13h
CUTS raised concerns regarding the effectiveness and proportionality of the proposed rules on Anti-Tobacco Disclaimers by the MoHFW
CUTS International, a prominent consumer health advocacy group, has submitted a detailed set of comments and suggestions on the proposed “Cigarette and Other Tobacco Products (Prohibition of ...
Pharmabiz13h
Aster Guardians Global Nursing Award announces top 10 finalists for 2024
Aster Guardians Global Nursing Award announces top 10 finalists for 2024: Our Bureau, Bengaluru Wednesday, October 16, 2024, 15:40 Hrs [IST] Aster DM Healthcare has unveiled the t ...
Pharmabiz14h
Meril Life Sciences empowers healthcare leaders with digital technologies to build supply chain efficiency
In line with their commitment to improve healthcare efficacy, Meril Life Sciences recently carried out a two-day practitioner ...
Pharmabiz17h
Lipella Pharmaceuticals’ innovative liposomal drug delivery platform receives US patent
Lipella Pharmaceuticals’ innovative liposomal drug delivery platform receives US patent: Pittsburgh Wednesday, October 16, 2024, 17:00 Hrs [IST] Lipella Pharmaceuticals Inc., a ...
Pharmabiz18h
Adayu unveils podcast series ‘Adayulogues’ on YouTube to raise awareness on mental health
Adayu unveils podcast series ‘Adayulogues’ on YouTube to raise awareness on mental health: Our Bureau, Bengaluru Wednesday, October 16, 2024, 16:30 Hrs [IST] Adayu, a Fortis G ...